Literature DB >> 20824507

Cardiac magnetic resonance determinants of functional mitral regurgitation in ischemic and non ischemic left ventricular dysfunction.

Covadonga Fernández-Golfín1, Alberto De Agustin, M Carmen Manzano, Ana Bustos, Tibisay Sánchez, Leopoldo Pérez de Isla, Manuel Fuentes, Carlos Macaya, José Zamorano.   

Abstract

Functional mitral regurgitation (FMR) is frequent in left ventricular (LV) dilatation/dysfunction. Echocardiographic predictors of FMR are known. However, cardiac magnetic resonance (CMR) predictors of FMR have not been fully addressed. The aim of the study was to evaluate CMR mitral valve (MV) parameters associated with FMR in ischemic and non ischemic LV dysfunction. 80 patients with LV ejection fraction below 45% and/or left ventricular dilatation of ischemic and non ischemic etiology were included. Cine-MR images (steady state free-precession) were acquired in a short-axis and 4 chambers views where MV evaluation was performed. Delayed enhancement was performed as well. Significant FMR was established as more than mild MR according to the echocardiographic report. Mean age was 59 years, males 79%. FMR was detected in 20 patients (25%) Significant differences were noted in LV functional parameters and in most MV parameters according to the presence of significant FMR. However, differences were noted between ischemic and non ischemic groups. In the first, differences in most MV parameters remained significant while in the non ischemic, only systolic and diastolic interpapillary muscle distance (1.60 vs. 2.19 cm, P = 0.001; 2. 51 vs. 3.04, P = 0.008) were predictors of FMR. FMR is associated with a more severe LV dilatation/dysfunction in the overall population. CMR MV parameters are associated with the presence of significant FMR and are different between ischemic and non ischemic patients. CMR evaluation of these patients may help in risk stratification as well as in surgical candidate selection.

Entities:  

Mesh:

Year:  2010        PMID: 20824507     DOI: 10.1007/s10554-010-9696-y

Source DB:  PubMed          Journal:  Int J Cardiovasc Imaging        ISSN: 1569-5794            Impact factor:   2.357


  18 in total

1.  Recommendations for evaluation of the severity of native valvular regurgitation with two-dimensional and Doppler echocardiography.

Authors:  William A Zoghbi; Maurice Enriquez-Sarano; Elyse Foster; Paul A Grayburn; Carol D Kraft; Robert A Levine; Petros Nihoyannopoulos; Catherine M Otto; Miguel A Quinones; Harry Rakowski; William J Stewart; Alan Waggoner; Neil J Weissman
Journal:  J Am Soc Echocardiogr       Date:  2003-07       Impact factor: 5.251

2.  Determinants of the degree of functional mitral regurgitation in patients with systolic left ventricular dysfunction: A quantitative clinical study.

Authors:  S F Yiu; M Enriquez-Sarano; C Tribouilloy; J B Seward; A J Tajik
Journal:  Circulation       Date:  2000-09-19       Impact factor: 29.690

3.  Echocardiographic predictors of successful versus unsuccessful mitral valve repair in ischemic mitral regurgitation.

Authors:  Vorachai Kongsaerepong; Maiko Shiota; A Marc Gillinov; Jong-Min Song; Shota Fukuda; Patrick M McCarthy; Timothy Williams; Robert Savage; Masao Daimon; James D Thomas; Takahiro Shiota
Journal:  Am J Cardiol       Date:  2006-06-21       Impact factor: 2.778

4.  Prognostic significance of functional mitral regurgitation after a first non-ST-segment elevation acute coronary syndrome.

Authors:  Leopoldo Perez de Isla; Jose Zamorano; Maribel Quezada; Carlos Almería; José Luis Rodrigo; Viviana Serra; Juan Carlos García Rubira; Antonio Fernandez Ortiz; Carlos Macaya
Journal:  Eur Heart J       Date:  2006-10-02       Impact factor: 29.983

5.  Contribution of ischemic mitral regurgitation to congestive heart failure after myocardial infarction.

Authors:  Francesco Grigioni; Delphine Detaint; Jean-François Avierinos; Christopher Scott; Jamil Tajik; Maurice Enriquez-Sarano
Journal:  J Am Coll Cardiol       Date:  2005-01-18       Impact factor: 24.094

6.  Ischemic mitral regurgitation: impact of the left ventricle and mitral valve in patients with left ventricular systolic dysfunction.

Authors:  Monvadi B Srichai; Richard A Grimm; Arthur E Stillman; A Marc Gillinov; L Leonardo Rodriguez; Michael L Lieber; Abigail Lara; Joan A Weaver; Patrick M McCarthy; Richard D White
Journal:  Ann Thorac Surg       Date:  2005-07       Impact factor: 4.330

7.  The echocardiographic determinants of functional mitral regurgitation differ in ischemic and non-ischemic cardiomyopathy.

Authors:  Mika Nagasaki; Satoshi Nishimura; Eiji Ohtaki; Hitoshi Kasegawa; Takayoshi Matsumura; Masatoshi Nagayama; Tetsuya Koyanagi; Tetsuya Tohbaru; Kazuhiko Misu; Ryuta Asano; Tetsuya Sumiyoshi; Saichi Hosoda
Journal:  Int J Cardiol       Date:  2006-04-04       Impact factor: 4.164

8.  Functional mitral regurgitation in chronic ischemic coronary artery disease: analysis of geometric alterations of mitral apparatus with magnetic resonance imaging.

Authors:  Hsi-Yu Yu; Mao-Yuan Su; Ta-Yu Liao; Hsu-Hsia Peng; Fang-Yue Lin; Wen-Yih Isaac Tseng
Journal:  J Thorac Cardiovasc Surg       Date:  2004-10       Impact factor: 5.209

Review 9.  Ischemic mitral regurgitation.

Authors:  J S Rankin; M S Hickey; L R Smith; L Muhlbaier; J G Reves; D B Pryor; A S Wechsler
Journal:  Circulation       Date:  1989-06       Impact factor: 29.690

10.  Mapping of mitral regurgitant defects by cardiovascular magnetic resonance in moderate or severe mitral regurgitation secondary to mitral valve prolapse.

Authors:  Ruvin S Gabriel; Andrew J Kerr; Owen C Raffel; Ralph A Stewart; Brett R Cowan; Christopher J Occleshaw
Journal:  J Cardiovasc Magn Reson       Date:  2008-04-09       Impact factor: 5.364

View more
  1 in total

Review 1.  Cardiovascular imaging 2011 in the International Journal of Cardiovascular Imaging.

Authors:  Ricardo A Costa; Hiram G Bezerra; Johan H C Reiber; Frank J Rybicki; Paul Schoenhagen; Arthur A Stillman; Johan De Sutter; Nico R L Van de Veire; Ernst E van der Wall
Journal:  Int J Cardiovasc Imaging       Date:  2012-03       Impact factor: 2.357

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.